PJ

Pasi Janne

DI Dana-Farber Cancer Institute: 32 patents #11 of 1,343Top 1%
The General Hospital: 11 patents #115 of 3,021Top 4%
BC Beth Israel Deaconess Medical Center: 2 patents #158 of 672Top 25%
YU Yale University: 2 patents #418 of 1,662Top 30%
University Of Texas System: 1 patents #2,951 of 6,559Top 45%
UH University Of North Carolina At Chapel Hill: 1 patents #769 of 1,688Top 50%
📍 Needham, MA: #30 of 796 inventorsTop 4%
🗺 Massachusetts: #2,781 of 88,656 inventorsTop 4%
Overall (All Time): #109,895 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 26–32 of 32 patents

Patent #TitleCo-InventorsDate
9758522 Hydrophobically tagged small molecules as inducers of protein degradation Nathanael S. Gray, Ting Xie, Sang-Min Lim, Craig M. Crews 2017-09-12
9035036 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch, Matthew Meyerson +4 more 2015-05-19
8715665 Methods for treating cancer resistant to ErbB therapeutics Jeffrey Engelman, Lewis C. Cantley 2014-05-06
8465916 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Bruce E. Johnston, Thomas J. Lynch, Matthew Meyerson +4 more 2013-06-18
8105769 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Bruce E. Johnston, Thomas J. Lynch, Matthew Meyerson +4 more 2012-01-31
7964349 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Bruce E. Johnston, Thomas J. Lynch, Matthew Meyerson +4 more 2011-06-21
7294468 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch, Matthew Meyerson +4 more 2007-11-13